Why Drug Interactions Are a Serious Consideration

This is an area that many cannabis resources underemphasize, and that oversight can be dangerous. Cannabis compounds — particularly THC and CBD — interact with the liver's cytochrome P450 (CYP450) enzyme system, the same system responsible for metabolizing a wide range of common medications.

If you take any prescription medications, over-the-counter drugs, or supplements, you need to understand how cannabis may affect the way your body processes them. This is not theoretical — it is a well-documented pharmacological interaction with real clinical consequences.

How the CYP450 System Works

Your liver uses a family of enzymes called cytochrome P450 (CYP450) to break down and process most of the medications you take. Think of these enzymes as a team of workers on an assembly line — each one is responsible for processing specific substances and removing them from your bloodstream at a predictable rate.

When cannabis enters the picture, it can disrupt this assembly line in two ways:

• Enzyme inhibition: Cannabis compounds can block (inhibit) certain CYP450 enzymes, causing other medications to remain in your system longer than expected. This effectively increases the dose of those medications, potentially leading to stronger effects, more side effects, or even toxicity. This is the more common interaction.
• Enzyme induction: In some cases, cannabis can speed up the activity of certain enzymes, causing medications to be broken down faster than expected. This reduces the medication's effectiveness, which can be equally dangerous — imagine your blood pressure medication or anti-seizure drug losing potency without you realizing it.

Which Enzymes Are Affected?

Research from the University of Sydney found that nearly all major cannabinoids inhibited CYP2C9 at clinically relevant concentrations. Most cannabinoids also inhibited CYP2C19.

Doohan et al., AAPS Journal, 2021

A separate study found that the interactions are extensive across multiple enzyme pathways:

• THC competitively inhibited CYP1A2, CYP2B6, CYP2C9, and CYP2D6
• CBD inhibited CYP3A4, CYP2B6, CYP2C9, CYP2D6, and CYP2E1

These are not obscure enzymes. CYP3A4 alone is responsible for metabolizing approximately 50% of all commonly prescribed medications. CYP2D6, CYP2C9, and CYP2C19 collectively handle a large portion of the remainder. This means the potential for interaction is broad.

Medications Requiring Particular Caution

The following medication categories have documented or strongly suspected interactions with cannabis compounds. This is not an exhaustive list — it covers the most clinically significant interactions.

Blood Thinners (Anticoagulants)

Medications: Warfarin (Coumadin), heparin, rivaroxaban (Xarelto), apixaban (Eliquis)

Cannabis can increase blood thinner levels in the body, raising the risk of bleeding. This interaction has been documented in multiple case reports. Warfarin is particularly concerning because it is metabolized by CYP2C9, one of the enzymes most strongly inhibited by cannabinoids.

• Patients on warfarin who begin using cannabis may see their INR (a measure of blood clotting speed) increase to dangerous levels
• Signs of excessive anticoagulation include unexplained bruising, bleeding gums, blood in urine or stool, and prolonged bleeding from cuts
• If you take blood thinners: Do not begin cannabis without first discussing it with the doctor who manages your anticoagulation therapy. More frequent INR monitoring may be necessary.

Anti-Seizure Medications (Anticonvulsants)

Medications: Valproate (Depakote), clobazam (Onfi), carbamazepine (Tegretol), phenytoin (Dilantin)

This category is particularly relevant because CBD itself is used to treat seizures (Epidiolex is FDA-approved for certain seizure disorders) — but CBD also interacts with other seizure medications. The interaction with clobazam is especially well-documented: CBD significantly increases clobazam levels, which can cause excessive sedation.

• Valproate combined with CBD has been associated with liver enzyme elevations, requiring monitoring of liver function
• Adjustments to anti-seizure medication doses may be necessary when cannabis is introduced
• If you take anti-seizure medication: This is a category where medical supervision is absolutely essential. Never adjust seizure medication doses on your own.

Transplant and Immunosuppressant Medications

Medications: Tacrolimus (Prograf), sirolimus (Rapamune), everolimus (Afinitor), cyclosporine (Sandimmune)

This is one of the most concerning interaction categories, with direct clinical evidence of harm.

Studies involving 35 patients found that 46% suffered adverse events related to medication toxicity when combining transplant/immunosuppressant drugs with cannabinoids.

Bansal et al., Frontiers in Pharmacology, 2024

Immunosuppressant medications have very narrow therapeutic windows — the difference between an effective dose and a toxic dose is small. When cannabis inhibits the enzymes that break down these drugs, blood levels can rise rapidly to dangerous concentrations.

• Elevated tacrolimus levels can cause kidney damage, tremors, and neurotoxicity
• For organ transplant recipients, medication toxicity can jeopardize the transplanted organ
• If you are a transplant recipient or take immunosuppressants: Do not use cannabis without explicit approval and monitoring from your transplant team. The 46% adverse event rate in studies should give serious pause.

Sedatives and Benzodiazepines

Medications: Diazepam (Valium), alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), zolpidem (Ambien)

Cannabis can enhance the sedative effects of these medications through two mechanisms: pharmacokinetic interaction (inhibiting the enzymes that break down benzodiazepines, raising their blood levels) and pharmacodynamic interaction (cannabis itself produces sedative effects that compound with benzodiazepine sedation).

• Excessive sedation can impair breathing, particularly during sleep
• Risk of falls increases significantly, especially in older adults
• Cognitive impairment may be more pronounced than expected from either substance alone
• If you take benzodiazepines: Discuss cannabis use with your prescribing doctor. Start with the lowest possible cannabis dose and be vigilant for excessive drowsiness. Never increase both substances simultaneously.

Certain Antidepressants

Medications: SSRIs (sertraline/Zoloft, fluoxetine/Prozac, citalopram/Celexa), tricyclic antidepressants (amitriptyline, nortriptyline), SNRIs (venlafaxine/Effexor, duloxetine/Cymbalta)

Cannabis and antidepressants share metabolic pathways through the CYP450 system. The interaction potential varies by specific medication:

• Fluoxetine (Prozac) is metabolized by CYP2D6, which CBD inhibits — potentially raising fluoxetine levels
• Sertraline (Zoloft) is metabolized by multiple CYP enzymes that cannabis affects
• Tricyclic antidepressants have a narrow therapeutic index, making them more sensitive to metabolic changes
• Both cannabis and serotonergic antidepressants can affect serotonin signaling, though the clinical significance of this overlap is not fully understood
• If you take antidepressants: Do not stop your antidepressant to try cannabis. Abruptly discontinuing SSRIs or SNRIs can cause discontinuation syndrome. Discuss adding cannabis with your prescribing doctor, and report any unusual symptoms (excessive sedation, serotonin-related symptoms like agitation, rapid heartbeat, or hyperthermia).

Opioid Pain Medications

Medications: Oxycodone (OxyContin, Percocet), hydrocodone (Vicodin), morphine, fentanyl, codeine, tramadol

The cannabis-opioid interaction is unique because it presents both risk and potential benefit:

• The risk: Cannabis can enhance the sedative and respiratory-depressant effects of opioids. Combining sedating substances always carries added risk.
• The potential benefit: Growing research suggests that cannabis may allow for reduced opioid doses under medical supervision. A 2025 JAMA Internal Medicine study showed a 22% reduction in opioid use among chronic pain patients in New York's medical cannabis program. A Canadian study found opioid use dropped from 28% to 11% of participants over 6 months.
• The critical distinction: Opioid dose reduction must be managed by a healthcare provider, not self-directed. Abrupt opioid cessation can cause severe, potentially life-threatening withdrawal. Any changes must be gradual and supervised.

For more on cannabis and opioid reduction, visit our Cannabis as Complement vs. Replacement page.

Quick Reference: Interaction Risk by Medication Category

What You Should Do

1. Make a complete medication list. Include all prescription drugs, over-the-counter medications (including NSAIDs like ibuprofen and acetaminophen), supplements, vitamins, and herbal products.
2. Bring the list to your healthcare provider. Tell them you are considering cannabis or are currently using it. Be completely honest — your safety depends on it.
3. Ask specifically about interactions. Not all doctors are trained in cannabis pharmacology, but they can look up interactions or refer you to a pharmacist who can.
4. Use the Penn State CANN-DIR tool. Penn State University has developed a free online tool specifically designed to identify potential cannabinoid-drug interactions. It is available at www.CANN-DIR.psu.edu. This tool is a starting point for conversation with your doctor, not a replacement for medical advice.
5. If you are cleared to use cannabis alongside medications, start with the lowest possible dose and increase gradually. Report any new or unusual symptoms to your doctor immediately.
6. Be especially cautious with CBD products. Over-the-counter CBD oils and supplements are widely available and often marketed as harmless. They are not — at least not from a drug interaction standpoint. CBD is a potent enzyme inhibitor and should be treated with the same caution as any other cannabis product if you take medications.

Further Reading

Studies Referenced on This Page

• Doohan et al. (2021), AAPS Journal — Cannabinoid interactions with CYP450 enzymes (University of Sydney)
• Bansal et al. (2024), Frontiers in Pharmacology — Systematic review of cannabis drug-drug interactions
• MDPI (2020), Journal of Clinical Medicine — Potential adverse drug events with THC
• PMC (2024) — Evaluation of potential drug-drug interactions with medical cannabis

Tools and Resources

• Penn State CANN-DIR — free online cannabinoid drug interaction checker
• Leaf411 — free consultations with cannabis-trained registered nurses
• Society of Cannabis Clinicians — find a healthcare provider trained in cannabis medicine

Related Pages on TryCannabis.org

• Who Should NOT Use Cannabis — populations at highest risk
• Why You Should Never Quit Medications Cold Turkey — critical safety information
• Cannabis as Complement vs. Replacement — the responsible approach to combining cannabis with medications
• Talking to Your Doctor — how to have this conversation